NZ513739A - Cloning of cDNA of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer - Google Patents
Cloning of cDNA of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancerInfo
- Publication number
- NZ513739A NZ513739A NZ513739A NZ51373900A NZ513739A NZ 513739 A NZ513739 A NZ 513739A NZ 513739 A NZ513739 A NZ 513739A NZ 51373900 A NZ51373900 A NZ 51373900A NZ 513739 A NZ513739 A NZ 513739A
- Authority
- NZ
- New Zealand
- Prior art keywords
- mage
- cdna
- cloning
- diagnosis
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26097899A | 1999-03-02 | 1999-03-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ513739A true NZ513739A (en) | 2001-09-28 |
Family
ID=22991462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ513739A NZ513739A (en) | 1999-03-02 | 2000-03-01 | Cloning of cDNA of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1194542A1 (ko) |
JP (1) | JP2003512814A (ko) |
KR (1) | KR20020011967A (ko) |
AU (1) | AU3389500A (ko) |
CA (1) | CA2366059A1 (ko) |
NZ (1) | NZ513739A (ko) |
WO (1) | WO2000052163A1 (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007053956A1 (en) | 2005-11-14 | 2007-05-18 | Universite Laval | Cancer antigen mage-a9 and uses thereof |
WO2019007974A1 (en) | 2017-07-07 | 2019-01-10 | Immatics Biotechnologies Gmbh | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NSCLC, CPPC AND OTHER CANCERS |
CR20210168A (es) | 2017-07-07 | 2021-06-10 | Immatics Biotechnologies Gmbh | Nuevos péptidos y nuevas combinaciones de péptidos para el uso en la inmunoterapia contra el cáncer de pulmón, incluyendo el nsclc, el sclc y otros cánceres |
FR3087448B1 (fr) | 2018-10-23 | 2023-10-13 | Pdc Line Pharma | Lignee pdc modifiee pour secreter une cytokine |
TW202039535A (zh) | 2018-12-18 | 2020-11-01 | 德商英麥提克生物技術股份有限公司 | B*08限制肽和肽組合物抗癌免疫治療和相關方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5342774A (en) * | 1991-05-23 | 1994-08-30 | Ludwig Institute For Cancer Research | Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1 |
US5612201A (en) * | 1991-05-23 | 1997-03-18 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecules useful in determining expression of a tumor rejection antigen precursor |
-
2000
- 2000-03-01 EP EP00912112A patent/EP1194542A1/en not_active Withdrawn
- 2000-03-01 NZ NZ513739A patent/NZ513739A/xx not_active Application Discontinuation
- 2000-03-01 WO PCT/US2000/005346 patent/WO2000052163A1/en not_active Application Discontinuation
- 2000-03-01 AU AU33895/00A patent/AU3389500A/en not_active Abandoned
- 2000-03-01 KR KR1020017011090A patent/KR20020011967A/ko not_active Application Discontinuation
- 2000-03-01 CA CA002366059A patent/CA2366059A1/en not_active Abandoned
- 2000-03-01 JP JP2000602775A patent/JP2003512814A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1194542A1 (en) | 2002-04-10 |
KR20020011967A (ko) | 2002-02-09 |
CA2366059A1 (en) | 2000-09-08 |
AU3389500A (en) | 2000-09-21 |
JP2003512814A (ja) | 2003-04-08 |
WO2000052163A1 (en) | 2000-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1042084A1 (en) | Substituted benzimidazoles and their preparation and use. | |
ZA200007040B (en) | Catalyst modifiers and their use in the polymerization of olefin(s). | |
EP1076090A2 (en) | ESTs and encoded human proteins | |
MXPA02004770A (es) | Composiciones terapeuticas y metodos para su uso. | |
GB9903841D0 (en) | Diagnosis and treatment of cancer | |
GB0106183D0 (en) | Improvements in or relating to the treatment of lesions | |
HK1047134A1 (zh) | 用於乳腺癌治療和診斷的組合物及其應用方法 | |
HUP0402489A3 (en) | 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine | |
WO1999029729A3 (en) | Antagonists of neuropilin receptor function and use thereof | |
PL352330A1 (en) | Derivatives of pyridopyranoazepine, making of same and use of same in therapy | |
AU4923200A (en) | Isothiazolecarboxamides and their use as microbicides | |
IL206604A (en) | Protein @ trans @membrane @@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@ @@ | |
AU2001250978A1 (en) | Polynucleotides and polypeptides, their use in diagnosis and treatment of cardiac, renal or inflammary disease | |
HK1031725A1 (en) | 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use | |
ZA97741B (en) | Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders. | |
HK1063629A1 (en) | 3,7-Diazabicyclo Ä3.3.0Üoctanes and their use in the treatment of cardiac arrhythmias | |
EP1210416A4 (en) | GENES CODING PROTEINS FOR DIAGNOSTIC, PREVENTIVE AND THERAPEUTIC USE | |
EP1208191A4 (en) | 13 PROTEINS ASSOCIATED WITH COLON CANCER AND HUMAN COLON | |
HUP0201997A3 (en) | Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications | |
IL160018A0 (en) | Isoxazolopyridinones and use thereof in the treatment of parkinson's disease | |
HUP0003811A3 (en) | Oxyranyle-triazoline thiones, their preparation and their use as microbicides | |
AU2890199A (en) | Gata-3-expression in human breast carcinoma | |
HK1042504A1 (en) | Human cervical cancer 1 protooncogene and protein encoded therein | |
NZ513739A (en) | Cloning of cDNA of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer | |
AU5618700A (en) | Extracellular camp-dependent protein kinase in diagnosis, prognosis and treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AVOD | Application void |